Drugs / Cogane™
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00875316 | Apr → Aug 2009 | Parkinson disease | Phytopharm | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cogane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00875316 ↗ |
| Known as | PYM50028 | “Cogane™ (PYM50028)” NCT00875316 ↗ |
| Route | Oral | “Daily Oral Administration” NCT00875316 ↗ |